First Patient Dosed in Emalex Biosciences Phase 2 Clinical Trial for Stuttering

Retrieved on: 2020-12-15 13:07:30

Tags for this article:

Branches of biology

Aromatic compounds

Dyslexia

Psychiatric diagnosis

Dopamine hypothesis of stuttering

Chicago

Click the tags to see associated articles and topics

First Patient Dosed in Emalex Biosciences Phase 2 Clinical Trial for Stuttering. View article details on hiswai:

Excerpt

... cell and gene therapy and <b>synthetic biology</b> utilizing artificial intelligence. The company's current portfolio includes Castle Creek Biosciences, CiRC ...

Article found on: www.newsbug.info

View Original Article